Avacta Life Sciences

At Avacta Life Sciences, our mission is to create a high quality, powerful set of tools to help Life Scientists accelerate the understanding of biology and disease and to help them apply these advances to diagnosis and treatment.

We have developed a revolutionary new alternative to antibodies and aptamers called Affimers. Based on a small protein scaffold that can be engineered to bind with high specificity and affinity to a wide range of protein targets, Affimers are engineered affinity proteins that are set to take the reagents market by storm.

With a groundbreaking 7 week custom service and a catalogue of unique binders, Affimers can be used for a wide range of applications in diagnostics, drug / biomarker discovery, biotech research & development and as therapeutic agents.

Whitepaper: Affimer® reagents facilitate affinity chromatography purification of proteins

Whitepaper: Identification of specific PD-L1 Affimer inhibitors with therapeutic potential

Interview with Amrik Basran, Chief Scientific Officer at Avacta Life Sciences

Avacta to develop Affimer reagents to reduce use of animals in research

The Science of Affimers

Affimers and Therapeutic Applications

An Introduction to Avacta Life Sciences

An Introduction to Affimers – the engineered antibody alternative

Rapid identification and characterisation of Affimer technology